Santa Clara, California (CA) Biological Specimens Manufacturers Companies

Featured companies
Seldon Custom Plasmas
P.O. BOX 334
Milpitas CA 95035
(408) 263-2198
Med Immune Vaccines Inc
3055 Patrick Henry Dr.
Santa Clara CA 95054
(650) 919-6500
B Bridge International Inc
4320 Stevens Creek Blvd.
San Jose CA 95129
(408) 615-8565
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Amgen Inc
5914 Exeter Court
San Jose CA 95138
(408) 531-8513
Stem Cells Inc
3155 Porter Dr.
Palo Alto CA 94304
(650) 475-3100
Medimmune Vaccines Inc
319 Bernardo Ave.
Mountain View CA 94043
(650) 919-6500
Bacti-Lab Inc
300 Pioneer Way # A
Mountain View CA 94041
(650) 968-3815
Med Immune Vaccines Inc
319 Bernardo Ave.
Mountain View CA 94043
(650) 919-6500
Shawn Bratcher
550 Ortega Ave APT 321b
Mountain View CA 94040
(650) 965-7627
Medimmune Vaccines
297 Bernardo Ave.
Mountain View CA 94043
(650) 691-9214
Protein Recovery Inc
13071 Jaccaranda CT
Saratoga CA 95070
(408) 741-0456
Whereorg has 11 results under Biological Specimens Manufacturers Companies in Santa Clara.

Narrow down the browsing criteria below to see more companies.

Select a location for category Biological Specimens Manufacturers


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020